Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.

Journal:

Journal of Clinical Oncology

Published:

2025-06-24

DOI:

10.1200/jco-24-02612

Affiliations:

18

Authors:

29

Go to article

Institutions	Authors	Share
USC Children's Hospital Los Angeles (CHLA), United States of America (USA)	10.000000 10.000000	0.34
University of Wisconsin-Madison (UW-Madison), United States of America (USA)	5.000000	0.17
UCSF Benioff Children's Hospital San Francisco, United States of America (USA)	2.000000	0.07
Woodruff Health Sciences Center (WHSC), Emory University, United States of America (USA)	1.500000	0.05
Aflac Cancer and Blood Disorders Center, CHOA, United States of America (USA)	1.500000	0.05
Cook Children's Medical Center, United States of America (USA)	1.000000	0.03
Cincinnati Children's Hospital Medical Center (CCHMC), United States of America (USA)	1.000000	0.03
Dana-Farber/Boston Children's Cancer and Blood Disorders Center, United States of America (USA)	1.000000	0.03
The University of Chicago (UChicago), United States of America (USA)	1.000000	0.03
University of Southern California (USC), United States of America (USA)	1.000000	0.03
Children's Hospital Colorado, United States of America (USA)	1.000000	0.03
St. Jude Children's Research Hospital (St. Jude), United States of America (USA)	1.000000	0.03
UW Medicine, United States of America (USA)	0.500000	0.02
Seattle Children's Hospital, United States of America (USA)	0.500000	0.02
University of Pennsylvania (Penn), United States of America (USA)	0.500000	0.02
Children's Hospital of Philadelphia (CHOP), United States of America (USA)	0.500000	0.02

Interested in Oncology and Carcinogenesis?